Close

VistaGen Therapeutics (VTGN) Granted Japanese Patent for AV-101 for Treatment of Depression and Hyperalgesia

February 19, 2019 8:37 AM EST Send to a Friend
VistaGen Therapeutics (NASDAQ: VTGN) today announced that the Japan Patent Office (JPO) has issued a patent related to methods of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login